187 related articles for article (PubMed ID: 30808675)
1. Antibody-Mediated Endocytosis of Polysialic Acid Enables Intracellular Delivery and Cytotoxicity of a Glycan-Directed Antibody-Drug Conjugate.
Cox EC; Thornlow DN; Jones MA; Fuller JL; Merritt JH; Paszek MJ; Alabi CA; DeLisa MP
Cancer Res; 2019 Apr; 79(8):1810-1821. PubMed ID: 30808675
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of the Receptor Interactions of Polysialic Acid (polySia), polySia Mimetics, and Sulfated Polysaccharides.
Zhang R; Loers G; Schachner M; Boelens R; Wienk H; Siebert S; Eckert T; Kraan S; Rojas-Macias MA; Lütteke T; Galuska SP; Scheidig A; Petridis AK; Liang S; Billeter M; Schauer R; Steinmeyer J; Schröder JM; Siebert HC
ChemMedChem; 2016 May; 11(9):990-1002. PubMed ID: 27136597
[TBL] [Abstract][Full Text] [Related]
3. Photothermal Therapy of Neuroblastoma via Polysialic Acid-Targeting Nanomissiles.
Xu S; Zhao M; Gu Z; Lu H; Liu Z
Small; 2022 Nov; 18(46):e2201671. PubMed ID: 36161701
[TBL] [Abstract][Full Text] [Related]
4. Polysialyltransferase: a new target in metastatic cancer.
Falconer RA; Errington RJ; Shnyder SD; Smith PJ; Patterson LH
Curr Cancer Drug Targets; 2012 Oct; 12(8):925-39. PubMed ID: 22463390
[TBL] [Abstract][Full Text] [Related]
5. A cancer-unique glycan: de-N-acetyl polysialic acid (dPSA) linked to cell surface nucleolin depends on re-expression of the fetal polysialyltransferase ST8SIA2 gene.
Moe GR; Steirer LM; Lee JA; Shivakumar A; Bolanos AD
J Exp Clin Cancer Res; 2021 Sep; 40(1):293. PubMed ID: 34544457
[TBL] [Abstract][Full Text] [Related]
6. Rapid Trimming of Cell Surface Polysialic Acid (PolySia) by Exovesicular Sialidase Triggers Release of Preexisting Surface Neurotrophin.
Sumida M; Hane M; Yabe U; Shimoda Y; Pearce OM; Kiso M; Miyagi T; Sawada M; Varki A; Kitajima K; Sato C
J Biol Chem; 2015 May; 290(21):13202-14. PubMed ID: 25750127
[TBL] [Abstract][Full Text] [Related]
7. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Antibody Targeting Sialyl-di-Lewis
Tivadar ST; McIntosh RS; Chua JX; Moss R; Parsons T; Zaitoun AM; Madhusudan S; Durrant LG; Vankemmelbeke M
Mol Cancer Ther; 2020 Mar; 19(3):790-801. PubMed ID: 31871270
[TBL] [Abstract][Full Text] [Related]
9. Molecular Interactions of the Polysialytransferase Domain (PSTD) in ST8Sia IV with CMP-Sialic Acid and Polysialic Acid Required for Polysialylation of the Neural Cell Adhesion Molecule Proteins: An NMR Study.
Liao SM; Lu B; Liu XH; Lu ZL; Liang SJ; Chen D; Troy Ii FA; Huang RB; Zhou GP
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111064
[TBL] [Abstract][Full Text] [Related]
10. Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.
Mohamed Amar IA; Huvelle S; Douez E; Letast S; Henrion S; Viaud-Massuard MC; Aubrey N; Allard-Vannier E; Joubert N; Denevault-Sabourin C
Eur J Med Chem; 2022 Feb; 229():114063. PubMed ID: 34974337
[TBL] [Abstract][Full Text] [Related]
11. CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110.
Domínguez JM; Pérez-Chacón G; Guillén MJ; Muñoz-Alonso MJ; Somovilla-Crespo B; Cibrián D; Acosta-Iborra B; Adrados M; Muñoz-Calleja C; Cuevas C; Sánchez-Madrid F; Avilés P; Zapata JM
J Hematol Oncol; 2020 Apr; 13(1):32. PubMed ID: 32264921
[TBL] [Abstract][Full Text] [Related]
12. Polysialic acid enhances the migration and invasion of human cytotrophoblasts.
Hromatka BS; Drake PM; Kapidzic M; Stolp H; Goldfien GA; Shih IeM; Fisher SJ
Glycobiology; 2013 May; 23(5):593-602. PubMed ID: 23208007
[TBL] [Abstract][Full Text] [Related]
13. The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells.
Poźniak M; Porębska N; Krzyścik MA; Sokołowska-Wędzina A; Jastrzębski K; Sochacka M; Szymczyk J; Zakrzewska M; Otlewski J; Opaliński Ł
Mol Med; 2021 May; 27(1):46. PubMed ID: 33962559
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the antigenic specificity of four different anti-(alpha 2-->8-linked polysialic acid) antibodies using lipid-conjugated oligo/polysialic acids.
Sato C; Kitajima K; Inoue S; Seki T; Troy FA; Inoue Y
J Biol Chem; 1995 Aug; 270(32):18923-8. PubMed ID: 7543897
[TBL] [Abstract][Full Text] [Related]
15. Expression of the neural cell adhesion molecule and polysialic acid in human neuroblastoma cell lines.
Valentiner U; Mühlenhoff M; Lehmann U; Hildebrandt H; Schumacher U
Int J Oncol; 2011 Aug; 39(2):417-24. PubMed ID: 21567084
[TBL] [Abstract][Full Text] [Related]
16. MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors.
Merlino G; Fiascarelli A; Bigioni M; Bressan A; Carrisi C; Bellarosa D; Salerno M; Bugianesi R; Manno R; Bernadó Morales C; Arribas J; Dusek RL; Ackroyd JE; Pham PH; Awdew R; Aud D; Trang M; Lynch CM; Terrett J; Wilson KE; Rohlff C; Manzini S; Pellacani A; Binaschi M
Mol Cancer Ther; 2019 Sep; 18(9):1533-1543. PubMed ID: 31227646
[TBL] [Abstract][Full Text] [Related]
17. Disialic, oligosialic and polysialic acids: distribution, functions and related disease.
Sato C; Kitajima K
J Biochem; 2013 Aug; 154(2):115-36. PubMed ID: 23788662
[TBL] [Abstract][Full Text] [Related]
18. Degree of polymerization (DP) of polysialic acid (polySia) on neural cell adhesion molecules (N-CAMS): development and application of a new strategy to accurately determine the DP of polySia chains on N-CAMS.
Nakata D; Troy FA
J Biol Chem; 2005 Nov; 280(46):38305-16. PubMed ID: 16172115
[TBL] [Abstract][Full Text] [Related]
19. Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design.
Maass KF; Kulkarni C; Betts AM; Wittrup KD
AAPS J; 2016 May; 18(3):635-46. PubMed ID: 26912181
[TBL] [Abstract][Full Text] [Related]
20. An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities.
Nicolazzi C; Caron A; Tellier A; Trombe M; Pinkas J; Payne G; Carrez C; Guérif S; Maguin M; Baffa R; Fassan M; Adam J; Mangatal-Wade L; Blanc V
Mol Cancer Ther; 2020 Aug; 19(8):1660-1669. PubMed ID: 32451330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
